Failure of lymphocyte microcytotoxicity to distinguish relapsers from non-relapsers in melanoma patients receiving post-surgical adjuvant chemotherapy
- 1 July 1978
- journal article
- research article
- Published by Elsevier
- Vol. 14 (7) , 793-797
- https://doi.org/10.1016/0014-2964(78)90011-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Effect of treatment with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) or 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) plus vincristine (NSC-67574) on lymphocyte reactivity of melanoma patientsCancer Immunology, Immunotherapy, 1977
- Current Concepts of the Biology of Human Cutaneous Malignant MelanomaAdvances in Cancer Research, 1977
- Sequentialin vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donorsInternational Journal of Cancer, 1975
- Lymphocyte toxicity test in clinical melanomaPublished by Elsevier ,1973
- Sequential studies on cell‐mediated tumor immunity and blocking serum activity in ten patients with malignant melanomaInternational Journal of Cancer, 1973
- Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanomaInternational Journal of Cancer, 1973
- ANTI‐TUMOUR IMMUNOREACTIVITY IN PATIENTS WITH MALIGNANT MELANOMAThe Medical Journal of Australia, 1972
- A MICROASSAY FOR CELL-MEDIATED IMMUNITYTransplantation, 1970